A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report

BACKGROUND: We have previousy reported on a Phase II study of S-1 monotherapy as a first line, combination therapy of S-1 plus cisplatin as a second line, and weekly paclitaxel monotherapy as a third line therapy in patients with advanced gastric carcinomas. The median survival time (MST) of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Rino, Yasushi, Yukawa, Norio, Murakami, Hitoshi, Wada, Nobuyuki, Yamada, Roppei, Hayashi, Tsutomu, Sato, Tsutomu, Ohshima, Takashi, Masuda, Munetaka, Imada, Toshio
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883242/
https://www.ncbi.nlm.nih.gov/pubmed/20567630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883242/
https://www.ncbi.nlm.nih.gov/pubmed/20567630

Ejemplares similares